Clinical trial
A Phase II Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence
NCT00123773 is registered in ClinicalTrials.gov with AHS Cancer Control Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence
- Lead sponsor
- AHS Cancer Control Alberta
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2004
- Completion date
- December 31, 2008
- Enrollment
- 1,075 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.